Press Releases

Date	Title
9/24/20	Vir Biotechnology Publishes New Research Characterizing Antibody Response to SARS-CoV-2 in the Journal Cell
9/9/20	Vir Biotechnology to Present at Cantor Global Virtual Healthcare Conference
9/8/20	Vir Biotechnology to Present at H.C. Wainwright 22nd Annual Global Investment Conference
9/1/20	Vir Biotechnology Appoints Janet Napolitano to its Board of Directors
8/31/20	Vir Biotechnology and GSK Start Phase 2/3 Study of COVID-19 Antibody Treatment
8/20/20	Vir Biotechnology Presents Data on VIR-2218 from Clinical Studies for the Treatment of Hepatitis B at the EASL Digital International Liver Congress™
8/11/20	Vir Biotechnology Provides Corporate Update and Reports Second Quarter 2020 Financial Results
7/28/20	Vir Biotechnology to Provide Corporate Update and Report Second Quarter 2020 Financial Results on August 11, 2020
7/10/20	Vir Biotechnology Appoints Elliott Sigal, M.D., Ph.D. to Board of Directors
7/10/20	Vir Biotechnology Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters’ Option to Purchase Additional Shares

Vir - Investor Relations Menu